Lv1
26 积分 2024-06-25 加入
Preclinical and Initial Clinical Evaluation of (68)Ga/(177)Lu-Labeled Heterodimer Agents Targeting Somatostatin Receptors and Integrin α(V)β(3)
3天前
已完结
Preclinical evaluation of a dual sstr2 and integrin α(v)β(3)-targeted heterodimer [(68)Ga]-NOTA-3PEG(4)-TATE-RGD
3天前
已完结
Evaluation of Lung Cancer and Neuroendocrine Neoplasm in a Single Scan by Targeting Both Somatostatin Receptor and Integrin αvβ3
3天前
已完结
A prospective head-to-head comparison of (68) Ga-NOTA-3P-TATE-RGD and (68) Ga-DOTATATE in patients with gastroenteropancreatic neuroendocrine tumours
3天前
已完结
Pharmacokinetics and Dosimetry of (177)Lu-DOTATATE in Patients with Advanced Well-Differentiated, Gastroenteropancreatic Neuroendocrine Tumors: Results from a Substudy of the Phase 3 XT-XTR008-3-01 Trial
27天前
已完结
Outcome-driven dosimetry optimization for [(177)Lu]Lu-PSMA-617 radiopharmaceutical therapy: proof of concept on single time point dosimetry optimization
27天前
已完结
Mass Dose Effects in FAP-Directed Imaging: Influence of Administered Dose of [(68)Ga]Ga-LNTH-1363S on Image Quality
2个月前
已关闭
Time-efficient and convenient synthesis of [(18)F]altanserin for human PET imaging by a new work-up procedure
2个月前
已完结
Automatic Synthesis of [(18)F]Altanserin, a Radiopharmaceutical for Positron Emission Tomographic Studies of the Serotonergic Type-2 Receptors
2个月前
已完结
Dosimetry Results from the Phase 1b/3 ACTION-1 Trial of [(225)Ac]Ac-DOTATATE (RYZ101) in Patients with Somatostatin Receptor-Expressing, Well-Differentiated GEP-NETs
2个月前
已完结
皖公网安备34019202002308
